EW vs KEYS · P/E 47, rev $1.39B vs P/E 57, rev $4.98B
Edwards Lifesciences Corp (EW) versus Keysight Technologies Inc (KEYS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Keysight Technologies Inc (KEYS) is a scientific & technical instruments company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported KEYS revenue for 2024-10-31 was $4.98B. Net income was $614.0M. Revenue was down 8.9% from 2023-10-31 to 2024-10-31. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
EW currently screens at market cap $49.91B and trailing P/E 46.9. KEYS currently screens at market cap $59.84B and trailing P/E 56.5.
Not investment advice. Open the EW and KEYS stock pages for the full models.
Not investment advice.